re: + updates + 23 Dec, 2004:
US FDA Grants Approval For Aridol Phase III Trial:
http://stocknessmonster.com/news-item?S=PXS&E=ASX&N=354608
18 Jan 2005: Applies for Regulatory Approval to market Aridol
http://stocknessmonster.com/news-item?S=PXS&E=ASX&N=356321
9 Febr: Pharmaxis to Commence UK Trial in Cystic Fibrosis
http://stocknessmonster.com/news-item?S=PXS&E=ASX&N=358485
23 Febr: US FDA Grants Bronchitol Orhpan Drug Status
http://stocknessmonster.com
2 March: Expands senior management team.
http://stocknessmonster.com/news-item?S=PXS&E=ASX&N=361578
Share price: $1.30
+ data and comment +, page-18
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
